Business Description
Taiyen Biotech Co Ltd
ISIN : TW0001737005
Description
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.32 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | 0.59 | |||||
| Interest Coverage | 113.46 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.12 | |||||
| Beneish M-Score | -2.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3 | |||||
| 3-Year EBITDA Growth Rate | -6.6 | |||||
| 3-Year EPS without NRI Growth Rate | -0.9 | |||||
| 3-Year FCF Growth Rate | 15.4 | |||||
| 3-Year Book Growth Rate | 1.4 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.28 | |||||
| 9-Day RSI | 48.59 | |||||
| 14-Day RSI | 51.86 | |||||
| 6-1 Month Momentum % | 3.69 | |||||
| 12-1 Month Momentum % | 5.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.44 | |||||
| Quick Ratio | 2.13 | |||||
| Cash Ratio | 1.59 | |||||
| Days Inventory | 75.37 | |||||
| Days Sales Outstanding | 28.52 | |||||
| Days Payable | 57.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.43 | |||||
| Dividend Payout Ratio | 0.63 | |||||
| Forward Dividend Yield % | 3.43 | |||||
| 5-Year Yield-on-Cost % | 3.13 | |||||
| Shareholder Yield % | 2.53 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.39 | |||||
| Operating Margin % | 15.1 | |||||
| Net Margin % | 10.85 | |||||
| FCF Margin % | 4.74 | |||||
| ROE % | 5.53 | |||||
| ROA % | 4.31 | |||||
| ROIC % | 6.13 | |||||
| 3-Year ROIIC % | -29.12 | |||||
| ROC (Joel Greenblatt) % | 10.51 | |||||
| ROCE % | 5.73 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.55 | |||||
| PE Ratio without NRI | 14.7 | |||||
| Shiller PE Ratio | 16.45 | |||||
| Price-to-Owner-Earnings | 39.02 | |||||
| PS Ratio | 2.13 | |||||
| PB Ratio | 1.08 | |||||
| Price-to-Tangible-Book | 1.09 | |||||
| Price-to-Free-Cash-Flow | 44.65 | |||||
| Price-to-Operating-Cash-Flow | 14.47 | |||||
| EV-to-EBIT | 13.18 | |||||
| EV-to-EBITDA | 8.82 | |||||
| EV-to-Revenue | 1.65 | |||||
| EV-to-FCF | 34.7 | |||||
| Price-to-Projected-FCF | 1.01 | |||||
| Price-to-Median-PS-Value | 1.04 | |||||
| Price-to-Graham-Number | 0.84 | |||||
| Price-to-Net-Current-Asset-Value | 6.53 | |||||
| Price-to-Net-Cash | 269.23 | |||||
| Earnings Yield (Greenblatt) % | 7.58 | |||||
| FCF Yield % | 2.22 | |||||
| Forward Rate of Return (Yacktman) % | 3.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Taiyen Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 3,302.035 | ||
| EPS (TTM) (NT$) | 1.79 | ||
| Beta | 0.19 | ||
| Volatility % | 8.15 | ||
| 14-Day RSI | 51.86 | ||
| 14-Day ATR (NT$) | 0.360279 | ||
| 20-Day SMA (NT$) | 35.12 | ||
| 12-1 Month Momentum % | 5.88 | ||
| 52-Week Range (NT$) | 32.9 - 36.35 | ||
| Shares Outstanding (Mil) | 200 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Taiyen Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Taiyen Biotech Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Taiyen Biotech Co Ltd Frequently Asked Questions
What is Taiyen Biotech Co Ltd(TPE:1737)'s stock price today?
The current price of TPE:1737 is NT$35.00. The 52 week high of TPE:1737 is NT$36.35 and 52 week low is NT$32.90.
When is next earnings date of Taiyen Biotech Co Ltd(TPE:1737)?
The next earnings date of Taiyen Biotech Co Ltd(TPE:1737) is .
Does Taiyen Biotech Co Ltd(TPE:1737) pay dividends? If so, how much?
The Dividend Yield %  of Taiyen Biotech Co Ltd(TPE:1737) is 3.43% (As of Today), Highest Dividend Payout Ratio of Taiyen Biotech Co Ltd(TPE:1737) was 1.05. The lowest was 0.47. And the median was 0.73. The  Forward Dividend Yield % of Taiyen Biotech Co Ltd(TPE:1737) is 3.43%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers